
Cardiology
Baxdrostat Adds an Option for Uncontrolled Hypertension
FDA approval adds baxdrostat as an aldosterone-targeted option for adults whose hypertension remains uncontrolled on combination therapy.
Rayan Salih · September 17, 2026 · 7 min
Stories from people navigating Hypertension — diagnosis, treatment, caregiving, and the ordinary days in between.
6 stories

Cardiology
FDA approval adds baxdrostat as an aldosterone-targeted option for adults whose hypertension remains uncontrolled on combination therapy.
Rayan Salih · September 17, 2026 · 7 min

Endocrinology & Metabolism
The supporting systematic review favors aldosterone-directed treatment and clearer selection between adrenalectomy and medical therapy for adults with primary aldosteronism.
Rayan Salih · 7 min read

Health Policy
A new WHO compendium standardizes clinical, operational and monitoring terminology for hypertension-control programs, giving health systems a shared basis for implementation, reporting and performance comparisons.
Dr. Abu Bakar · 6 min read

Cardiology
The 2026 guideline retains a 130/80 mm Hg diagnostic threshold but links medication timing to cardiovascular, diabetes and kidney risk. Most treated adults share a target below 130/80 mm Hg.
Rayan Salih · 7 min read

Women's Health
Postpartum preeclampsia — high blood pressure and related organ problems that begin after childbirth — is a condition
Rayan Salih · 8 min read

Cardiology
There is an ever increasing epidemic of obesity amongst African American women, already disproportionately affected by high rates
Dr. Abu Bakar · 12 min read
Other conditions
One story a day
One health journey each morning — no advice, no alarm, just company for the road.